Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +1.43% | +2.90% | +151.33% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Nektar Therapeutics Reiterates Earnings Guidance for the Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+151.33% | 261M | |
+42.69% | 749B | |
+38.81% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.65% | 248B | |
-2.54% | 214B | |
+11.26% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Oppenheimer Adjusts Nektar Therapeutics Price Target to $3 From $5, Maintains Perform Rating